Enzyme Creates Drug Resistant Bacteria

focusInternational travel has changed many things in the medical world and 50 UK residents coming down with a drug resistant form of bacteria emphasize the need for good infection control. The medical community needs to be ready for anything and they need plans in place to keep bacterial infections from spreading.

A virulent enzyme has the capability of making bacteria that are resistant to all of the best antibiotic medications including carbapenems, the last line of defense in terms of antibiotic drugs. In the past three years 50 UK residents have had this enzyme which has caused antibiotic resistant bacteria.

In this case the enzyme that causes drug resistant bacteria is the New Dehli Metallo-beta-lactamase -1 (NDM-1). In India 1 to 3 percent of patients already have this enzyme. However, here in the UK it is a new problem. Many of the 50 patients sought medical treatment in India or the India subcontinent. Some of them were treated in local hospitals while on vacation and others went there seeking plastic surgery options. Others were treated for accidents in Turkey and Greece and came home with the enzyme. While most of the cases can be tracked back to these over seas visits, there remain a few that aren’t traceable.

Most patients who have come down with this enzyme have had serious infections with two of them being fatal. Though it should be noted that those that were fatal also had other serious health concerns, all patients with the enzyme had to have long term treatment and spent a great deal of time in isolation units. There are very few antibiotics show any effectiveness on these bacterial infections.

673854_doctor_patient_relationshipAccording to the Health Protection Agency the enzyme that causes bacteria to be resistant is a, “notable public health risk.” Dr. David Livermore is the co-author of the Lantent study that has provided the information about the NDM bacteria. He noted that the spread of these bacteria, “underscores the need for good infection control.” These methods need to be implemented in UK hospitals as well as overseas. It is also important for new antibiotics to be developed.

The biggest thing that can be stressed at this point is to come up with good infection control that is effective in stopping the spread of the enzyme.

Add a Comment

Your email address will not be published. Required fields are marked *